Central Trust Company’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-264
Closed -$9K 1303
2018
Q1
$9K Buy
+264
New +$10.1K ﹤0.01% 1010
2017
Q3
Sell
-60
Closed -$3K 1323
2017
Q2
$3K Buy
+60
New +$3.21K ﹤0.01% 1129
2016
Q3
Sell
-1,035
Closed -$57K 1159
2016
Q2
$57K Sell
1,035
-5
-0.5% -$275 ﹤0.01% 640
2016
Q1
$56K Buy
+1,040
New +$51.2K ﹤0.01% 644

Other funds holding PBH

Central Trust Company's PBH Position: Q2 2018 in Review

Central Trust Company sold out of Prestige Consumer Healthcare (PBH) in Q2 2018, closing a stake of 264 shares — an estimated $9K sold.

Central Trust Company first reported a position in PBH in Q1 2016 and held it in 4 quarters. The position peaked at $57K in Q2 2016. 237 funds tracked by Wall St. Rank hold PBH as of Q2 2018.

  • Central Trust Company reported no remaining Prestige Consumer Healthcare position as of Q2 2018 after selling out during the quarter.
  • Central Trust Company sold 264 Prestige Consumer Healthcare shares in Q2 2018, an estimated $9K.
  • Central Trust Company first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 4 quarters.
  • Central Trust Company's Prestige Consumer Healthcare position peaked at $57K in Q2 2016.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2018.

Based on Central Trust Company's 13F filing for Q2 2018, filed 9 Jul 2018.